Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jan;31(1):413-414.
doi: 10.1007/s11695-020-04799-4.

Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic

Chia Siang Kow  1 , Syed Shahzad Hasan  2
Affiliations
Comment

Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic

Chia Siang Kow et al. Obes Surg. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Comment on

  • Obesity and COVID-19: ACE 2, the Missing Tile.
    Iannelli A, Favre G, Frey S, Esnault V, Gugenheim J, Bouam S, Schiavo L, Tran A, Alifano M. Iannelli A, et al. Obes Surg. 2020 Nov;30(11):4615-4617. doi: 10.1007/s11695-020-04734-7. Obes Surg. 2020. PMID: 32451913 Free PMC article. No abstract available.

References

    1. Iannelli A, Favre G, Frey S, et al. Obesity and COVID-19: ACE 2, the missing tile. Obes Surg. 2020;2020:1–3. - PMC - PubMed
    1. Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020;2020:1–16. - PMC - PubMed
    1. Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020;2020:dc200660. - PubMed
    1. Marhl M, Grubelnik V, Magdič M, Markovič R. Diabetes and metabolic syndrome as risk factors for COVID-19. Diabetes Metab Syndr. 2020;14(4):671–677. doi: 10.1016/j.dsx.2020.05.013. - DOI - PMC - PubMed
    1. Shyangdan DS, Royle P, Clar C, Sharma P, Waugh N, Snaith A. Glucagon-like peptide analogues for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2011;2011(10):CD006423. - PMC - PubMed